Professor DM Thomas

There’s a Revolution in Cancer. But Can Big Pharma Afford It? Revolution Medicines could soon launch a pancreatic-cancer drug. Its stock may already be beyond what established pharmaceutical firms can pay cc @Aiims1742 @DavidHongMD wsj.com/finance/invest…

Genome pioneer Craig Venter dies: here’s how he transformed science. I can't forget his talk to our Big Ideas seminary series last year. Vale. nature.com/articles/d4158…

This is a saddening turn in the remarkable story around this manuscript. This paper achieved unseen popular attention and its content was positioned as a new hope for patients with #PancreaticCancer - the lack of transparency is concerning.

@Suryanshti777 Worth a listen.

A man spends 50 years teaching at MIT. He knows his time is running out. So he records one last lecture — everything he knows, distilled into a single hour. He died 5 months later. This is that lecture. The most important hour you'll watch this week. 👇 Bookmark it for later

Love this from @Nature briefing this am: Species with longer names — such as Myxococcus llanfairpwllgwyngyllgogerychwyrndrobwllllantysiliogogogochensis (longest ever scientific name) get fewer citations and Wikipedia reads.

2. Read @VivekSubbiah commentary here jamanetwork.com/journals/jamao… @UNSW

1. Excited to share the first results from @Omico's MoST program (2016-21): overall survival extended from 12.8-21.2 months for well-matched therapies jamanetwork.com/journals/jamao…

This experiment breaks your brain 🤯 Remove air in the world’s largest vacuum chamber, drop a bowling ball and feathers, and Galileo is proven right—400 years later.

I was thrilled to hear that a recent scan showed my brain tumour area is still looking pretty good. It’s simply amazing to still be here enjoying life! I’m incredibly grateful to the outstanding medical team who care for me so well. Thank you Helen Wheeler, Michael Back, Marina Kastelan and colleagues for your dedicated teamwork. Best wishes to everyone including during our Aussie summer months! @NthSydHealth @Sydney_Uni #glioblastoma #braincancer #Brainstorm

How can we measure the value of #genomics in #healthcare? How can #HTA, #implementation & data management be adapted to suit the rapidly evolving nature of genomics technologies? A new Review from Zornitza Stark, @IliasGoranitis & colleagues addresses these questions. nature.com/articles/s4159…

🚨 End-of-year treat! “Eleven clinical trials that will shape medicine in 2026” is now FREE to access 🧬 Discover next-gen vaccines, gene-editing tools, and long COVID therapies poised to redefine treatment. 👉 ow.ly/UOcY50XLxcg #NatureMedicine #ClinicalTrial

ASCO daily news: on the importance of recognizing rare cancers, listening to patients, and performing NGS to optimize therapy dailynews.ascopubs.org/do/strategic-a…

@ScienceMagazine Isn’t materials science amazing??

Researchers in Science have developed a clear, high-insulating material they say could be used to produce ultra-efficient windows and thus reduce the energy use of buildings dramatically worldwide. 📄: scim.ag/3KLkXPx #SciencePerspective: scim.ag/4rQQiRK

First-in-class YAP/TEAD Inhibitor Shows Promise in Hippo-driven Mesothelioma | Cancer Discovery News | American Association for Cancer Research aacrjournals.org/cdnews/news/29…

Bedside to Bench — AI and the New Science of Medicine | New England Journal of Medicine nejm.org/doi/full/10.10…

ESMO Sarcoma and Rare Cancers 2026: Why register youtu.be/C9xdG-PxtJg?si… via @YouTube

⭐️ Blown away by the flood of DMs, emails & texts 👉🏼from leaders across industry & academia, echoing alignment with our JCO commentary: “Precision Oncology and Modernizing Evidence Standards.” Deep thanks to @JCO_ASCO @ASCO for publishing it.🙏🏽🎉 @OncoAlert @Dr_R_Kurzrock ascopubs.org/doi/10.1200/JC…

⭐️All roads lead to ROME: convergence of evidence in precision oncology - @myESMO @ESMO_Open esmoopen.com/article/S2059-…

Hans Gelderblom, David M. Thomas, and Peter Horak discussed "Omics to Guide Precision Therapy" in a plenary session to close out the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. #Targets25 @ProfDMThomas